The separation relies on differences in cell density rather than immune-cell identity. After blood is diluted and layered over a density-gradient medium, centrifugation produces distinct regions: PBMCs remain at the plasma–gradient interface, whereas denser erythrocytes and granulocytes move below the gradient. This physical separation concentrates lymphocytes and monocytes for downstream investigation.
Ficoll provides the density-gradient medium that enables blood components to distribute into separate layers during centrifugation. Its position beneath the diluted blood creates an interface where the less dense mononuclear cells collect, while erythrocytes and granulocytes sediment farther downward. The resulting band can be recovered for washing and subsequent cellular or molecular analysis.
The recovered fraction is enriched mainly for lymphocytes and monocytes, the mononuclear cells most relevant to many immune studies. Erythrocytes and granulocytes are separated below the gradient rather than collected with this fraction. Consequently, the preparation provides a focused starting population for examining immune-cell behavior, infection-related responses, or inflammatory processes.
Once the PBMC layer is recovered from the plasma–gradient interface, the cells can be washed to remove residual gradient medium and other separated material. Researchers may then count the cells, culture them, or prepare them for flow cytometry and molecular assays. These steps convert the isolated fraction into a defined input for experiments and measurements.
This preparation is useful when investigators need access to circulating mononuclear immune cells for studying host–pathogen interactions, inflammation, vaccine responses, or infectious-disease biomarkers. Because lymphocytes and monocytes are recovered as a workable cell fraction, the same starting material can support functional studies, cellular profiling, or molecular analysis across diverse immune and infection experiments.
Separated PBMCs can provide material for several complementary outcomes. Cell counting measures the recovered population, culture enables investigation of cellular function, flow cytometry supports analysis of immune-cell characteristics, and molecular assays examine biological signals. Together, these approaches can help evaluate immune responses, infection-associated changes, vaccine effects, and candidate biomarkers in the studied samples.